Explore Events

The Alliance for Health Policy is a nonpartisan, nonprofit organization dedicated to helping policymakers and the public better understand health policy, the root of the nation’s health care issues, and the trade-offs posed by various proposals for change.

Upcoming Events

Explore our curated selection of American health care events, designed to inspire and inform as you navigate the ever-evolving landscape of medical advancements and policy changes.

Join Our Event List

Join our event newsletter to stay up to date on our latest events and webinars.

No upcoming events at this time. Visit our past events below and come back soon to check on upcoming events.

Signature Series

Courageous Conversations. Innovative Events.

The annual Signature Series addresses challenging issues in health policy by convening cross-sector dialogue with experts in both policy and practice. Together, we critically examine and identify what’s at stake, as well as key areas of opportunity.

This year’s theme focuses on the transformative power of Artificial Intelligence (AI) in health care and health policy.

 

Past Events

Filter Past Events

Topics

Event Type

Reset
October 5, 2015

With the third open enrollment period for health insurance marketplaces launching November 1st, this briefing took a detailed look at what consumers can expect regarding premiums, health plan availability and affordability. Speakers provided the latest information about premium trends and drivers, health plan availability and new tools designed to help consumers make informed choices. They highlighted changes from […]

September 21, 2015

This briefing, the third in a series on creating a more consumer-friendly and patient-centered health care system, delved into the issues that patients face as they make decisions about their health care. It explored questions such as: What does it mean for patients to be engaged in their care? What information and tools are available to empower […]

September 18, 2015

  Innovative drugs have brought about significant progress in treating costly and complex conditions. While there is agreement among many stakeholders that some of these breakthrough drugs have had a positive impact on Americans’ health and life expectancy, increasing prices have also caused some confusion about the methods by which drug prices are determined. The […]

August 7, 2015

This briefing, the first in a three-part series exploring the intersection of health and social policy, focused on Medicaid and housing policy. What does evidence say about the relationship between stable housing and health outcomes for various populations? What financial impact can housing have on Medicaid costs, and what potential role can Medicaid play regarding […]

July 24, 2015

This briefing, the second in a three-part series on the role of consumers and patients in our health care system, discussed the role of consumers in today’s health care coverage market, exploring questions such as: How is the evolving insurance marketplace affecting the choices consumers have when selecting a health plan, whether through a health […]

July 1, 2015

In advance of the third open enrollment period for health coverage under the Affordable Care Act, this briefing examined coverage trends, who has gained coverage and who remains uninsured, and why those uninsured individuals have not obtained coverage. Speakers also discussed insurance marketplace efforts to expand the focus from primarily enrollment to include assisting consumers […]

June 12, 2015

The Affordable Care Act (ACA) created new health insurance marketplaces for small businesses, known as Small Business Health Options Program (SHOP) marketplaces, and made substantial changes to the regulation of health insurance for small businesses. For purposes of health insurance regulation, small businesses have traditionally been defined by states as businesses with up to 50 […]

June 5, 2015

This briefing told you what you need to know about a major Supreme Court challenge to the Affordable Care Act (ACA). The Court is expected to make a decision in June, and a ruling for the King petitioners could mean that individuals will no longer be able to receive subsidies to purchase health insurance through […]

May 20, 2015

With Congress focused intently on the discovery, development, and delivery pipeline for innovative drugs and devices – and in the wake of the first-ever U.S. approval of a biosimilar medication– key policy and regulatory questions are being actively debated, with important implications for industry, patients, and the health care system. This briefing provided essential background […]

Join Our Event List

Contact events@allhealthpolicy.org for more info.